Mitochondria as disease-relevant organelles in rheumatoid arthritis

Mitochondria in RA macrophages. Synovial tissue Mφ (STM) are a highly heterogeneous population in terms of mitochondrial activity, metabolic networks, and functional commitment. MERTKhi pro-resolving STM are committed to highly active oxidative phosphorylation (OXPHOS), based on the elevated expression of mitochondria-encoded ETC subunit genes. Conversely, pro-inflammatory STM, which mostly lack MERTK, upregulate glucose and lactate transporters and rely more on glycolysis and the pentose phosphate pathway for energy supply. Pro-inflammatory Mφ upregulate the glycolytic enzyme pyruvate kinase M2 (PKM2) to feed pyruvate into the mitochondria, generate ample ATP as well as ROS. PKM2 is sensitive to ROS-imposed structural changes and transitions into the nucleus to function as a driver of pro-inflammatory cytokines and tissue-injurious enzymes. Hyperactive mitochondria form membrane interaction sites with the ER, so-called MAMs, that support calcium exchange, sustaining high metabolic and functional activity of RA Mφ. Mφ that are functionally active in the synovial tissue environment need to be able to adapt to the harsh conditions of the tissue niche: a hypoxic, glucose deplete microenvironment. RA Mφ adjust to the bioenergetic conditions in synovial tissue by upregulating the transcription factor RFX5. RFX5 target genes include the enzyme glutamate dehydrogenase 1 (GLUD1), which allows the cells to metabolize glutamate into alpha-ketoglutarate and fuel the TCA cycle. In parallel, RFX5 controls the density of HLA-DR molecules on the cell surface, guiding the cells’ antigen-presenting function. RFX5 is induced by the small cytokine CCL18 and functions as a potent coordinator of antigen-presenting capabilities and successful survival in a glucose deplete environment
Mitochondria as disease-relevant organelles in rheumatoid arthritis

Publication

Mitochondria as disease-relevant organelles in rheumatoid arthritis. (2023) Cornelia M Weyand, et al. Clin Exp Immunol. 2023 Mar;211(3):208-223. Figure: F4.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates SLC2A1 SLC2A1 ncbigene_symbol SLC2A1 6513
Homo sapiens Primates CIII C3 ncbigene_symbol C3 718
Homo sapiens Primates SLC1A5 SLC1A5 ncbigene_symbol SLC1A5 6510
Homo sapiens Primates GLUD1 GLUD1 ncbigene_symbol GLUD1 2746
Homo sapiens Primates GLUD1 GLUD1 ncbigene_synonym GRID1 2894
Homo sapiens Primates ATP ATP ncbigene_synonym ATP8A2 51761
Homo sapiens Primates PKM2 PKM2 ncbigene_synonym PKM 5315
Homo sapiens Primates PKM2 PKM2 famplex_relations PKLR 5313
Homo sapiens Primates MAM MAM ncbigene_synonym SGCG 6445
Homo sapiens Primates RFX5 RFX5 ncbigene_symbol RFX5 5993
Homo sapiens Primates HLA-DR HLADR famplex_relations HLA-DRA 3122
Homo sapiens Primates HLA-DR HLADR famplex_relations HLA-DRB1 3123
Homo sapiens Primates HLA-DR HLADR famplex_relations HLA-DRB3 3125
Homo sapiens Primates HLA-DR HLADR famplex_relations HLA-DRB4 3126
Homo sapiens Primates HLA-DR HLADR famplex_relations HLA-DRB5 3127
Homo sapiens Primates SLC16A3 SLC16A3 ncbigene_symbol SLC16A3 9123
Homo sapiens Primates STAT3 STAT3 ncbigene_symbol STAT3 6774
Homo sapiens Primates CCL18 CCL18 ncbigene_symbol CCL18 6362
Homo sapiens Primates IL-6 IL-6 ncbigene_synonym IL6 3569
Homo sapiens Primates IL-18/IL-6 IL-18 ncbigene_synonym IL18 3606

Chemical mentions

Word Match MeSH Name ChEBI
Glutamine Arg-Gln mesh:C578860 arginyl-glutamine chebi:73813
Glucose Glucose mesh:D005947 D-glucopyranose chebi:4167
monocarboxylate NA mesh:C434677
ATP Adenosine Triphosphate mesh:D000255 ATP chebi:15422
Pyruvate NA mesh:D011773
Glutamate NA
Lactate NA mesh:D019344

Disease mentions

Word Match MeSH Name DOID